检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:白艺兰 费荣梅[1] BAI Yi-lan;FEI Rong-mei(Key Laboratory of Animal Bacteriology,Ministry of Agriculture and Rural Affairs,Nanjing Agricultural University,Nanjing 210095,China;Shanghai Animal Disease Prevention and Control Center,Shanghai 201103,China)
机构地区:[1]南京农业大学农业农村部动物细菌开放实验室,江苏南京210095 [2]上海市动物疫病预防控制中心,上海201103
出 处:《中国兽医科学》2022年第2期184-189,共6页Chinese Veterinary Science
摘 要:为了进一步研究扬子鳄IFN-α,构建原核表达载体pET32a-IFN,导入大肠杆菌表达系统后诱导表达,并纯化靶蛋白。使用纯化重组蛋白作为抗原,加入佐剂乳化后免疫3只雌性的6周龄BALB/c小鼠,免疫后第35天对小鼠采血分离血清并测定效价。结果显示,成功构建原核表达载体pET32a-IFN,Western-blot鉴定显示,扬子鳄IFN-α重组蛋白成功表达,大小与预期相符,约为43 ku;免疫后的1号和2号小鼠所产生的多克隆抗体效价均为1∶51200,3号小鼠所产生的多克隆抗体效价为1∶25600,具有良好的特异性,这为后续扬子鳄IFN-α抗病毒的研究奠定了基础。In order to further study the Chinese alligator IFN-α,the prokaryotic expression vector p ET32 a-IFN was constructed and introduced into the Escherichia coli expression system,target recombinant protein was induced and purified,and was used as the antigen to immunize 3 female 6-week-old BALB/c mice after emulsification with adjuvant for antibody.On the 35 th day,blood was collected from the mice to separate the serum and its titer was determined,and the response between antigen and antibody was done by Western-blot.The results showed that the prokaryotic expression vector p ET32 a-IFN was successfully constructed,and Western-blot identification showed that the Chinese alligator IFN-αrecombinant protein was successfully expressed,and the protein size was about 43 ku as expected.The titer of polyclonal antibodies produced by mice No.1 and No.2 is 1∶51200,and the polyclonal antibody produced by mice No.3 is 1∶25600,all of which have good specificity.The experiment laid the foundation for the follow-up research on the antiviral effect of Chinese alligator IFN-α.
关 键 词:IFN-Α 扬子鳄 原核表达 蛋白纯化 多克隆抗体
分 类 号:S852.42[农业科学—基础兽医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.66